Raysearch Laboratories
119.4 SEK -1%1 investor is following this company
RaySearch Laboratories is a biotechnology company. The company specializes in the development of software solutions for the healthcare industry. An area where the company's products are used is in the treatment of cancer and other serious diseases. The company's products include products for dose planning and information systems. Various features include machine learning, computational speed, automated planning, virtual simulation, adaptive therapy, and digital workflows. The products are used by several clinics around the global market.
Read moreRevenue
1.02B
EBIT %
11.24 %
P/E
50.17
Dividend yield-%
1.68 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
RAY B
Daily low / high price
117.6 / 122.4
SEK
Market cap
4.09B SEK
Turnover
2.75M SEK
Volume
23K
Financial calendar
Interim report
17.05.2024
General meeting
22.05.2024
Annual dividend
23.05.2024
Bonus dividend
23.05.2024
Interim report
16.08.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Johan Löf | 16.5 % | 53.0 % |
Northern Trust Company, London Branch | 8.3 % | 2.8 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
RaySearch Laboratories: RaySearch to present the latest advances in RayStation, RayCare and RayIntelligence at ESTRO 2024
RaySearch Laboratories: RaySearch publishes Annual Report for 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools